Ben Hsieh joined PARC when it first ventured into biomedical sciences. As part of this effort, Ben established both the infrastructure and protocols for several biomedical research projects -- including DNA microarray printing, protein purification, and immunofluorescent detection of circulating rare (cancer and fetal) cells. He also established PARC's capability to do protein expression, genetic analysis, and gene expression profiling of these occult cells. Ben hopes to someday redefine cancer prognostics and fetal diagnostics through the discoveries made at PARC.
As part of PARC's Cleantech Innovation Program, Ben currently works on clean water -- continuing his quest to use technology to help solve environmental issues.
Ben brings broad expertise in biochemical engineering and life sciences from years of postdoctoral research at University of California, Irvine, and Lawrence Berkeley National Laboratory. He has 14 issued patents.
related focus areas
in the news view all
The FAST track to better health
28 April 2008 | Economist.com Technology Monitor
news releases view all